135 related articles for article (PubMed ID: 12566077)
21. Changes in prostate-specific antigen (PSA) level correlate with growth inhibition of prostate cancer cells treated in vitro with a novel anticancer drug, irofulven.
Woynarowska BAHigdon AL; Muñoz RM; Bushong P; Waters SJ
Invest New Drugs; 2001; 19(4):283-91. PubMed ID: 11561687
[TBL] [Abstract][Full Text] [Related]
22. A new pyrrole based small molecule from Tinospora cordifolia induces apoptosis in MDA-MB-231 breast cancer cells via ROS mediated mitochondrial damage and restoration of p53 activity.
Rashmi KC; Harsha Raj M; Paul M; Girish KS; Salimath BP; Aparna HS
Chem Biol Interact; 2019 Feb; 299():120-130. PubMed ID: 30543781
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of glutathione synthesis overcomes Bcl-2-mediated topoisomerase inhibitor resistance and induces nonapoptotic cell death via mitochondrial-independent pathway.
Yoshida A; Takemura H; Inoue H; Miyashita T; Ueda T
Cancer Res; 2006 Jun; 66(11):5772-80. PubMed ID: 16740716
[TBL] [Abstract][Full Text] [Related]
24. Antitumor activity of irofulven monotherapy and in combination with mitoxantrone or docetaxel against human prostate cancer models.
Van Laar ES; Weitman S; MacDonald JR; Waters SJ
Prostate; 2004 Apr; 59(1):22-32. PubMed ID: 14991863
[TBL] [Abstract][Full Text] [Related]
25. Enhanced antitumor activity of irofulven in combination with 5-fluorouracil and cisplatin in human colon and ovarian carcinoma cells.
Poindessous V; Koeppel F; Raymond E; Cvitkovic E; Waters SJ; Larsen AK
Int J Oncol; 2003 Nov; 23(5):1347-55. PubMed ID: 14532976
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of JNK2 and JNK3 by JNK inhibitor IX induces prometaphase arrest-dependent apoptotic cell death in human Jurkat T cells.
Jang WY; Lee JY; Lee ST; Jun do Y; Kim YH
Biochem Biophys Res Commun; 2014 Sep; 452(3):845-51. PubMed ID: 25218503
[TBL] [Abstract][Full Text] [Related]
27. Differential cytotoxicity and induction of apoptosis in tumor and normal cells by hydroxymethylacylfulvene (HMAF).
Woynarowska BA; Woynarowski JM; Herzig MC; Roberts K; Higdon AL; MacDonald JR
Biochem Pharmacol; 2000 May; 59(10):1217-26. PubMed ID: 10736422
[TBL] [Abstract][Full Text] [Related]
28. FAM3B/PANDER inhibits cell death and increases prostate tumor growth by modulating the expression of Bcl-2 and Bcl-X
Maciel-Silva P; Caldeira I; de Assis Santos I; Carreira ACO; Siqueira FR; Antonioli E; Goldberg AC; Belizário JE; Garay-Malpartida HM
BMC Cancer; 2018 Jan; 18(1):90. PubMed ID: 29357840
[TBL] [Abstract][Full Text] [Related]
29. NADPH alkenal/one oxidoreductase activity determines sensitivity of cancer cells to the chemotherapeutic alkylating agent irofulven.
Dick RA; Yu X; Kensler TW
Clin Cancer Res; 2004 Feb; 10(4):1492-9. PubMed ID: 14977853
[TBL] [Abstract][Full Text] [Related]
30. Preferential targeting of apoptosis in tumor versus normal cells.
Woynarowska BA; Woynarowski JM
Biochim Biophys Acta; 2002 Jul; 1587(2-3):309-17. PubMed ID: 12084473
[TBL] [Abstract][Full Text] [Related]
31. Molecular mechanisms of curcumin-induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt.
Woo JH; Kim YH; Choi YJ; Kim DG; Lee KS; Bae JH; Min DS; Chang JS; Jeong YJ; Lee YH; Park JW; Kwon TK
Carcinogenesis; 2003 Jul; 24(7):1199-208. PubMed ID: 12807727
[TBL] [Abstract][Full Text] [Related]
32. Activation and the interaction of proapoptotic genes in modulating sensitivity to anticancer drugs in gastric cancer cells.
Kim R; Ohi Y; Inoue H; Toge T
Int J Oncol; 1999 Oct; 15(4):751-6. PubMed ID: 10493958
[TBL] [Abstract][Full Text] [Related]
33. Characterizations of irofulven cytotoxicity in combination with cisplatin and oxaliplatin in human colon, breast, and ovarian cancer cells.
Serova M; Calvo F; Lokiec F; Koeppel F; Poindessous V; Larsen AK; Laar ES; Waters SJ; Cvitkovic E; Raymond E
Cancer Chemother Pharmacol; 2006 Apr; 57(4):491-9. PubMed ID: 16075278
[TBL] [Abstract][Full Text] [Related]
34. Phase I clinical and pharmacokinetic trial of irofulven.
Thomas JP; Arzoomanian R; Alberti D; Feierabend C; Binger K; Tutsch KD; Steele T; Marnocha R; Smith C; Smith S; MacDonald J; Wilding G; Bailey H
Cancer Chemother Pharmacol; 2001 Dec; 48(6):467-72. PubMed ID: 11800027
[TBL] [Abstract][Full Text] [Related]
35. Molecular mechanism of apoptosis induction by Gaillardin, a sesquiterpene lactone, in breast cancer cell lines : Gaillardin-induced apoptosis in breast cancer cell lines.
Fallahian F; Aghaei M; Abdolmohammadi MH; Hamzeloo-Moghadam M
Cell Biol Toxicol; 2015 Dec; 31(6):295-305. PubMed ID: 26843455
[TBL] [Abstract][Full Text] [Related]
36. Bcl-2 inhibits early apoptotic events and reveals post-mitotic multinucleation without affecting cell cycle arrest in human epithelial tumor cells exposed to etoposide.
Elliott MJ; Murphy KM; Stribinskiene L; Ranganathan V; Sturges E; Farnsworth ML; Lock RB
Cancer Chemother Pharmacol; 1999; 44(1):1-11. PubMed ID: 10367743
[TBL] [Abstract][Full Text] [Related]
37. The broad-range cyclin-dependent kinase inhibitor UCN-01 induces apoptosis in colon carcinoma cells through transcriptional suppression of the Bcl-x(L) protein.
Bhonde MR; Hanski ML; Magrini R; Moorthy D; Müller A; Sausville EA; Kohno K; Wiegand P; Daniel PT; Zeitz M; Hanski C
Oncogene; 2005 Jan; 24(1):148-56. PubMed ID: 15467762
[TBL] [Abstract][Full Text] [Related]
38. Bcl-xL modulates apoptosis induced by anticancer drugs and delays DEVDase and DNA fragmentation-promoting activities.
Schmitt E; Cimoli G; Steyaert A; Bertrand R
Exp Cell Res; 1998 Apr; 240(1):107-21. PubMed ID: 9570926
[TBL] [Abstract][Full Text] [Related]
39. Docetaxel induces Bcl-2- and pro-apoptotic caspase-independent death of human prostate cancer DU145 cells.
Ogura T; Tanaka Y; Tamaki H; Harada M
Int J Oncol; 2016 Jun; 48(6):2330-8. PubMed ID: 27082738
[TBL] [Abstract][Full Text] [Related]
40. Eupafolin, a flavonoid isolated from Artemisia princeps, induced apoptosis in human cervical adenocarcinoma HeLa cells.
Chung KS; Choi JH; Back NI; Choi MS; Kang EK; Chung HG; Jeong TS; Lee KT
Mol Nutr Food Res; 2010 Sep; 54(9):1318-28. PubMed ID: 20397191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
